Advertisement

Detection and Characterization of Circulating ICAM-1

  • Elizabeth A. Mainolfi
  • Steven D. Marlin
  • Robert Rothlein
Conference paper

Abstract

Over the past several years, the expression of intercellular adhesion molecule-1 (ICAM-1) on cells from normal and diseased tissue has been extensively studied. Almost as soon as ICAM-1 was identified, it was found to be a cell-surface adhesion molecule that was inducible in vitro with inflammatory cytokines such as IL-1, TNFα, and IFNγ on a multitude of cell types. Furthermore, ICAM-1’s expression on cells from normal and diseased tissue has been and continues to be a focus of much research from many laboratories. To date, it has been reported that there is a low constitutive expression of ICAM-1 on venule endothelial cells; however, its expression is markedly increased at inflammatory sites (1). Furthermore, there is an increased ICAM-1 expression on multiple cell types including keratinocytes in inflammatory skin lesions (2,3), transplanted liver bile duct and perivenular hepatocytes during rejection (4), and in cases of primary biliary cirrhosis (5), endothelium in the brain surrounding MS plaques and EAE lesions in man and rodent, respectively (6–12), transplanted kidney glomeruli and tubules during rejection (13), as well as lung epithelial cells following antigen provocation (14). Increased ICAM-1 is also found on melanoma cells following metastasis (15,16) and recently ICAM-1 expression has been shown to be expressed on placental macrophages and decidua during pregnancy.

Keywords

Primary Biliary Cirrhosis Acute Rejection Liver Allograft Leukocyte Adhesion Deficiency Venule Endothelial Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dustin, M.L., R. Rothlein, A.K. Bhan, C.A. Dinarello, and T.A. Springer. 1986. Induction by IL-1 and interferon, tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 137:245.PubMedGoogle Scholar
  2. 2.
    Vejlsgaard, G.L., E. Ralfkiaer, C. Avnstorp, M. Czajkowski, S.D. Marlin, and R. Rothlein. 1989. Kinetics and characterization of intercellular adhesion molecule-1 (ICAM-1) expression on keratinocytes in various inflammatory skin lesions and malignant cutaneous lymphomas. J. Amer. Acad. Dermtol. 20:782.CrossRefGoogle Scholar
  3. 3.
    Griffiths, C.E.M. and B.J. Nickoloff. 1989. Keratinocyte intercellular adhesion molecule-1 (ICAM-1) expression precedes dermal T lymphocytic infiltration in allergic contact dermatitis (Rhus dermatitis). Am. J. Pathol. 135:1045.PubMedGoogle Scholar
  4. 4.
    Adams, D.H., S.G. Hubscher, J. Shaw, R. Rothlein, and J.M. Neuberger. 1989. Intercellular adhesion molecule 1 on liver allografts during rejection. Lancet 2:1122.PubMedCrossRefGoogle Scholar
  5. 5.
    Adams, D.H., S.G. Hubscher, J. Shaw, G.D. Johnson, C. Babbs, R. Rothlein, and J.M. Neuberger. 1991. Increased expression of intercellular adhesion molecule 1 on bile ducts in primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology 14:426.PubMedCrossRefGoogle Scholar
  6. 6.
    Sobel, R.A., M.E. Mitchell, and G. Fondren. 1990. Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am. J. Pathol. 136:1309.PubMedGoogle Scholar
  7. 7.
    Frohman, E.M., T.C. Frohman, M.L. Dustin, B. Vayuvegula, B. Choi, A. Gupta, S. van den Noort, and S. Gupta. 1989. Induction of ICAM-1 expression on human fetal astrocytes by interferon-gamma, tumor necrosis factor-alpha and interleukin-1: relevance to intracerebral antigen presentation. J. Neuroimmunol. 23:117.PubMedCrossRefGoogle Scholar
  8. 8.
    Raine, C.S., S.C. Lee, L.C. Scheinberg, A.M. Duijvestijn, and A.H. Cross. 1990. Adhesion molecules on endothelial cells in the central nervous system: An emerging area in the neuroimmunology of multiple sclerosis. Clin. Immunol. Immunopathol. 57:173.PubMedCrossRefGoogle Scholar
  9. 9.
    Cannella, B., A.H. Cross, and C.S. Raine. 1990. Upregulation and coexpres-sion of adhesion molecules correlate with relapsing autoimmune demyelina-tion in the central nervous system. J. Exp. Med. 172:1521.PubMedCrossRefGoogle Scholar
  10. 10.
    Cannella, B., A.H. Cross, and C.S. Raine. 1991. Adhesion-related molecules in the central nervous system: Upregulation correlates with inflammatory cell influx during relapsing experimental autoimmune encephalomyelitis. Lab. Invest. 65:23.PubMedGoogle Scholar
  11. 11.
    Raine, C.S. 1991. Multiple sclerosis: A pivotal role for the T cell in lesion development. Neuropathol. Appl. Neurobiol. 17:265.PubMedCrossRefGoogle Scholar
  12. 12.
    Wilcox, C.E., A.M.V. Ward, A. Evans, D. Baker, R. Rothlein, and J.L. Turk. 1990. Endothelial cell expression of the intercellular adhesion molecule-1 (ICAM-1) in the central nervous system of guinea pigs during acute and chronic relapsing experimental allergic encephalomyelitis. J. Neuroimmunol. 30:43.PubMedCrossRefGoogle Scholar
  13. 13.
    Cosimi, A.B., D. Conti, F.L. Delmonico, F.I. Preffer, S.-L. Wee, R. Rothlein, R. Faanes, and R.B. Colvin. 1990. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J. Immunol. 144:4604.PubMedGoogle Scholar
  14. 14.
    Wegner, CD., R.H. Gundel, P. Reilly, N. Haynes, L.G. Letts, and R. Rothlein. 1990. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 247:456.PubMedCrossRefGoogle Scholar
  15. 15.
    Matsui, M., M. Temponi, and S. Ferrone. 1987. Characterization of a monoclonal antibody-defined human melanoma-associated antigen susceptible to induction by immune interferon. J. Immunol. 139:2088.PubMedGoogle Scholar
  16. 16.
    Natali, P., M.R. Nicotra, R. Cavaliere, A. Bigotti, G. Romano, M. Temponi, and S. Ferrone. 1990. Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. Cancer Res. 50:1271.PubMedGoogle Scholar
  17. 17.
    Staunton, D.E., S.D. Marlin, C. Stratowa, M.L. Dustin, and T.A. Springer. 1988. Primary structure of intercellular adhesion molecule 1 (ICAM-1) demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 52:925.PubMedCrossRefGoogle Scholar
  18. 18.
    Simmons, D., M.W. Makgoba, and B. Seed. 1988. ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM. Nature 331:624.PubMedCrossRefGoogle Scholar
  19. 19.
    Greve, J.M., G. Davis, A.M. Meyer, C.P. Forte, S.C. Yost, C.W. Marlor, M.E. Kamarck, and A. McClelland. 1989. The major human rhinovirus receptor is ICAM-1. Cell 56:839.PubMedCrossRefGoogle Scholar
  20. 20.
    Staunton, D.E., V.J. Merluzzi, R. Rothlein, R. Barton, S.D. Marlin, and T.A. Springer. 1989. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 56:849.PubMedCrossRefGoogle Scholar
  21. 21.
    Marlin, S.D., D.E. Staunton, T.A. Springer, C. Stratowa, W. Sommergruber, and V.J. Merluzzi. 1990. A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection. Nature 344:70.PubMedCrossRefGoogle Scholar
  22. 22.
    Rubin, L.A., C.C. Kurman, M.E. Fritz, W.E. Biddison, B. Boutin, R. Yarchoan, and D.L. Nelson. 1985. Soluble interleukin receptors are released from activated human lymphoid cells in vitro. J. Immunol. 135:3172.PubMedGoogle Scholar
  23. 23.
    Gordon, J., J.A. Cairns, M.J. Millsum, G.R. Guy, and S. Gillis. 1988. Interleukin and soluble CD23 as progression factors for human B-lymphocytes. Eur. J. Immunol. 18:1561.PubMedCrossRefGoogle Scholar
  24. 24.
    Rothlein, R., E.A. Mainolfi, M. Czajkowski, and S.D. Marlin. 1991. A form of circulating ICAM-1 in human serum. J. Immunol. 147:3788.PubMedGoogle Scholar
  25. 25.
    Kishimoto, T.K. and T.A. Springer. 1989. Human leukocyte adhesion deficiency: Molecular basis for a defective immune response to infections of the skin. In Current Problems in Dermatology. 18:106.Google Scholar
  26. 26.
    Ballantyne, C., E.A. Mainolfi, J.B. Young, N.T. Windsor, B. Cocanougher, E.C. Lawrence, D.C. Anderson, and R. Rothlein. 1991. Prognostic value of increased levels of circulating intercellular adhesion adhesion molecule-1 after heart transplant. Clin. Res. 39#2:285a.Google Scholar
  27. 27.
    Adams, D.H., E.A. Mainolfi, J. Neuberger, E. Elias, and R. Rothlein. 1991. Secretion of circulating ICAM-1 into bile during liver allograft rejection. Gut 32:A576.CrossRefGoogle Scholar
  28. 28.
    Adams, D.H., P. Burra, E.A. Mainolfi, J. Nueberger, E. Elias, and R. Rothlein. 1991. Circulating ICAM-1 in chronic liver disease: evidence for lymphocyte activation in PBC and PSC. J. Hepatol. 13:s3.Google Scholar
  29. 29.
    Johnson, J.P., B.G. Stade, B. Holzmann, W. Schwable, and G. Riethmuller. 1989. De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc. Natl. Acad. Sci. U. S. A. 86:641.PubMedCrossRefGoogle Scholar
  30. 30.
    Harning, R., E.A. Mainolfi, J.C. Bystryn, M. Henn, V.J. Merluzzi, and R. Rothlein. 1991. Serum levels of circulating intercellular adhesion molecule 1 in human malignant melanoma. Cancer Res. 51:5003.PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1993

Authors and Affiliations

  • Elizabeth A. Mainolfi
  • Steven D. Marlin
  • Robert Rothlein

There are no affiliations available

Personalised recommendations